SCHEMBL5390002

SCHEMBL5390002

Brc1cc2c3c(cccc3c1)CC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP3A4 P08684 2/20 0.37
CYP2A6 P11509 1/20 0.37
TSHR P16473 1/20 0.37
CYP1B1 Q16678 1/20 0.36
MAPT P10636 4/20 0.35
ALDH1A1 P00352 4/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
MEN1 O00255 2/20 0.35
GAA P10253 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NQO1 P15559 1/20 0.33
HSD17B3 P37058 3/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13725894 0.92 PRNP (0.39) NPSR1LMNAHSD17B10CYP3A4CYP2A6
SCHEMBL13725878 0.80 ALDH1A1 (0.38) NPSR1LMNAHSD17B10CYP3A4CYP2A6
SCHEMBL13726502 0.78 BIRC5 (0.44) LMNAHSD17B10TSHRMAPTALDH1A1
Acenaphthene SCHEMBL28028969 0.77 TSHR (0.57) LMNAHSD17B10CYP3A4TSHRCYP1B1
Acenaphthene SCHEMBL9017 0.77 TSHR (0.57) LMNAHSD17B10CYP3A4TSHRCYP1B1
Acenaphthene SCHEMBL3416108 0.77 TSHR (0.57) LMNAHSD17B10CYP3A4TSHRCYP1B1
Acenaphthene SCHEMBL1162573 0.77 TSHR (0.57) LMNAHSD17B10CYP3A4TSHRCYP1B1
Acenaphthene SCHEMBL598252 0.77 TSHR (0.57) LMNAHSD17B10CYP3A4TSHRCYP1B1
Acenaphthene SCHEMBL29386207 0.77 TSHR (0.57) LMNAHSD17B10CYP3A4TSHRCYP1B1
SCHEMBL1004222 0.76 CYP3A4 (0.65) NPSR1LMNAHSD17B10CYP3A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-62230790-A None JP disclosed
CN-113518789-B Resin composition, and prepreg, resin-equipped film, resin-equipped metal foil, metal-clad laminate and wiring board using the same 松下知识产权经营株式会社 2024-08-06 CN disclosed
CN-117720787-A Flexible metal clad laminate and method of making the same 科腾聚合物荷兰有限责任公司 2024-03-19 CN disclosed
CN-112020523-B Resin composition, prepreg, resin-coated film, resin-coated metal foil, metal foil-clad laminate, and wiring board 松下知识产权经营株式会社 2023-10-24 CN disclosed
CN-113795377-A Copper-clad laminate, resin-coated copper foil, and circuit board using same 松下知识产权经营株式会社 2021-12-14 CN disclosed
CN-113518789-A Resin composition, prepreg using same, resin-containing film, resin-containing metal foil, metal-clad laminate, and wiring board 松下知识产权经营株式会社 2021-10-19 CN disclosed
CN-112020523-A Resin composition, prepreg, film with resin, metal foil with resin, metal-foil-clad laminate, and wiring board 松下知识产权经营株式会社 2020-12-01 CN disclosed
CN-101595100-A Piperidines as the heterocyclic substituted of ORL-1 part PURDUE PHARMA LP (US) 2009-12-02 CN disclosed
US-20090200929-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO. LTD. (JP) 2009-08-13 US disclosed
US-20090200929-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO. LTD. (JP) 2009-08-13 US disclosed
US-7504526-B2 Anthracene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2009-03-17 US disclosed
US-7504526-B2 Anthracene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2009-03-17 US disclosed
US-20070248911-A1 Pattern forming method and bilayer film IWASAWA HARUO 2007-10-25 US disclosed
US-7244549-B2 Pattern forming method and bilayer film JSR CORPORATION (JP) 2007-07-17 US disclosed
EP-1754696-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-02-21 EP disclosed
US-20030073040-A1 Pattern forming method and bilayer film JSR CORPORATION (JP) 2003-04-17 US disclosed
US-4939223-A Silicon-modified polyimides NIPPON STEEL CHEMICAL CO., LTD. (JP) 1990-07-03 US disclosed
JP-S62230790-A ORGANOSILICON COMPOUND NIPPON STEEL CHEM CO LTD 1987-10-09 JP disclosed
EP-0017915-A1 Use of phototropic organic compounds to control the transmission of electromagnetic radiation, and phototropic compounds BASF Aktiengesellschaft (DE) 1980-10-29 EP disclosed
US-4212813-A OXIDIZING ACENAPHTHENES, COBALT COMPOUND CATALYST NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1980-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090200929-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME ALKBH2, ANXA7, ANXA2 NPSR1 4875/4885LMNA 244/4885HSD17B10 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.